Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BBT-176 |
Trade Name | |
Synonyms | BBT176|BBT 176 |
Drug Descriptions |
BBT-176 is a 4th generation EGFR inhibitor with enhanced activity against C797S-containing EGFR triple mutants, potentially leading to tumor growth inhibition (PMID: 37249619). |
DrugClasses | EGFR Inhibitor 4th gen 16 |
CAS Registry Number | NA |
NCIT ID | C180519 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BBT-176 | BBT-176 | 0 | 0 |
BBT-176 + Cetuximab | BBT-176 Cetuximab | 0 | 0 |
BBT-176 + Osimertinib | BBT-176 Osimertinib | 0 | 0 |